1-14 of 14
Sijin Wen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Personalized Medicine for Patients with Advanced Cancer in the Phase I Program at MD Anderson: Validation and Landmark Analyses

Apostolia-Maria Tsimberidou, Sijin Wen, David S. Hong, Jennifer J. Wheler, Gerald S. Falchook, Siqing Fu, Sarina Piha-Paul, Aung Naing, Filip Janku, Kenneth Aldape, Yang Ye, Razelle Kurzrock, Donald Berry
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (18): 4827–4836.
https://doi.org/10.1158/1078-0432.CCR-14-0603
Published: 14 September 2014
View article titled, Personalized Medicine for Patients with Advanced Cancer in the Phase I Program at MD Anderson: Validation and Landmark Analyses
Open the PDF for Personalized Medicine for Patients with Advanced Cancer in the Phase I Program at MD Anderson: Validation and Landmark Analyses in another window
Includes: Supplementary data
Journal Articles

Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer

Ana M. Aparicio, Andrea L. Harzstark, Paul G. Corn, Sijin Wen, John C. Araujo, Shi-Ming Tu, Lance C. Pagliaro, Jeri Kim, Randall E. Millikan, Charles Ryan, Nizar M. Tannir, Amado J. Zurita, Paul Mathew, Wadih Arap, Patricia Troncoso, Peter F. Thall, Christopher J. Logothetis
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (13): 3621–3630.
https://doi.org/10.1158/1078-0432.CCR-12-3791
Published: 30 June 2013
View article titled, Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer
Open the PDF for Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative

Apostolia-Maria Tsimberidou, Nancy G. Iskander, David S. Hong, Jennifer J. Wheler, Gerald S. Falchook, Siqing Fu, Sarina Piha-Paul, Aung Naing, Filip Janku, Rajyalakshmi Luthra, Yang Ye, Sijin Wen, Donald Berry, Razelle Kurzrock
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (22): 6373–6383.
https://doi.org/10.1158/1078-0432.CCR-12-1627
Published: 14 November 2012
View article titled, Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative
Open the PDF for Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative in another window
Includes: Supplementary data
Journal Articles

Survival of 1,181 Patients in a Phase I Clinic: The MD Anderson Clinical Center for Targeted Therapy Experience

Jennifer Wheler, Apostolia M. Tsimberidou, David Hong, Aung Naing, Gerald Falchook, Sarina Piha-Paul, Siqing Fu, Stacy Moulder, Bettzy Stephen, Sijin Wen, Razelle Kurzrock
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (10): 2922–2929.
https://doi.org/10.1158/1078-0432.CCR-11-2217
Published: 14 May 2012
View article titled, Survival of 1,181 Patients in a Phase I Clinic: The MD Anderson Clinical Center for Targeted Therapy Experience
Open the PDF for Survival of 1,181 Patients in a Phase I Clinic: The MD Anderson Clinical Center for Targeted Therapy Experience in another window
Includes: Supplementary data
Journal Articles

Phase I Clinical Trial Outcomes in 93 Patients with Brain Metastases: The MD Anderson Cancer Center Experience

Apostolia Maria Tsimberidou, Katherine Letourneau, Sijin Wen, Jennifer Wheler, David Hong, Aung Naing, Nancy G. Iskander, Cynthia Uehara, Razelle Kurzrock
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (12): 4110–4118.
https://doi.org/10.1158/1078-0432.CCR-10-3095
Published: 15 June 2011
View article titled, Phase I Clinical Trial Outcomes in 93 Patients with Brain Metastases: The MD Anderson Cancer Center Experience
Open the PDF for Phase I Clinical Trial Outcomes in 93 Patients with Brain Metastases: The MD Anderson Cancer Center Experience in another window
Includes: Supplementary data
Journal Articles

Cytoplasmic Sequestration of p27 via AKT Phosphorylation in Renal Cell Carcinoma

Jinhee Kim, Eric Jonasch, Angela Alexander, John D. Short, Shengli Cai, Sijin Wen, Dimitra Tsavachidou, Pheroze Tamboli, Bogdan A. Czerniak, Kim Anh Do, Kevin J. Wu, Laura A. Marlow, Christopher G. Wood, John A. Copland, Cheryl Lyn Walker
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (1): 81–90.
https://doi.org/10.1158/1078-0432.CCR-08-0170
Published: 31 December 2008
View article titled, Cytoplasmic Sequestration of p27 via AKT Phosphorylation in Renal Cell Carcinoma
Open the PDF for Cytoplasmic Sequestration of p27 via AKT Phosphorylation in Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Soluble ErbB3 Levels in Bone Marrow and Plasma of Men with Prostate Cancer

Sue-Hwa Lin, Yu-Chen Lee, Michel B. Choueiri, Sijin Wen, Paul Mathew, Xiangcang Ye, Kim-Anh Do, Nora M. Navone, Jeri Kim, Shi-Ming Tu, Li-Yuan Yu-Lee, Christopher J. Logothetis
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (12): 3729–3736.
https://doi.org/10.1158/1078-0432.CCR-08-0472
Published: 16 June 2008
View article titled, Soluble ErbB3 Levels in Bone Marrow and Plasma of Men with Prostate Cancer
Open the PDF for Soluble ErbB3 Levels in Bone Marrow and Plasma of Men with Prostate Cancer in another window
Journal Articles

The Prognostic Significance of Serum β2 Microglobulin Levels in Acute Myeloid Leukemia and Prognostic Scores Predicting Survival: Analysis of 1,180 Patients

Apostolia-Maria Tsimberidou, Hagop M. Kantarjian, Sijin Wen, Susan O'Brien, Jorge Cortes, William G. Wierda, Charles Koller, Sherry Pierce, Mark Brandt, Emil J. Freireich, Michael J. Keating, Elihu H. Estey
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (3): 721–730.
https://doi.org/10.1158/1078-0432.CCR-07-2063
Published: 01 February 2008
View article titled, The Prognostic Significance of Serum β<sub>2</sub> Microglobulin Levels in Acute Myeloid Leukemia and Prognostic Scores Predicting Survival: Analysis of 1,180 Patients
Open the PDF for The Prognostic Significance of Serum β<sub>2</sub> Microglobulin Levels in Acute Myeloid Leukemia and Prognostic Scores Predicting Survival: Analysis of 1,180 Patients in another window
Journal Articles

Platelet-Derived Growth Factor Receptor Inhibition and Chemotherapy for Castration-Resistant Prostate Cancer with Bone Metastases

Paul Mathew, Peter F. Thall, Corazon D. Bucana, William K. Oh, Michael J. Morris, Donnah M. Jones, Marcella M. Johnson, Sijin Wen, Lance C. Pagliaro, Nizar M. Tannir, Shi-Ming Tu, Anthony A. Meluch, Lon Smith, Lorenzo Cohen, Sun-Jin Kim, Patricia Troncoso, Isaiah J. Fidler, Christopher J. Logothetis
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19): 5816–5824.
https://doi.org/10.1158/1078-0432.CCR-07-1269
Published: 01 October 2007
View article titled, Platelet-Derived Growth Factor Receptor Inhibition and Chemotherapy for Castration-Resistant Prostate Cancer with Bone Metastases
Open the PDF for Platelet-Derived Growth Factor Receptor Inhibition and Chemotherapy for Castration-Resistant Prostate Cancer with Bone Metastases in another window
Journal Articles

Initial Modulation of the Tumor Microenvironment Accounts for Thalidomide Activity in Prostate Cancer

Eleni Efstathiou, Patricia Troncoso, Sijin Wen, Kim-Anh Do, Curtis A. Pettaway, Louis L. Pisters, Timothy J. McDonnell, Christopher J. Logothetis
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (4): 1224–1231.
https://doi.org/10.1158/1078-0432.CCR-06-1938
Published: 22 February 2007
View article titled, Initial Modulation of the Tumor Microenvironment Accounts for Thalidomide Activity in Prostate Cancer
Open the PDF for Initial Modulation of the Tumor Microenvironment Accounts for Thalidomide Activity in Prostate Cancer in another window
Journal Articles

Cancer-Testis Antigens: Expression and Correlation with Survival in Human Urothelial Carcinoma

Padmanee Sharma, Yu Shen, Sijin Wen, Dean F. Bajorin, Victor E. Reuter, Lloyd J. Old, Achim A. Jungbluth
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (18): 5442–5447.
https://doi.org/10.1158/1078-0432.CCR-06-0527
Published: 25 September 2006
View article titled, Cancer-Testis Antigens: Expression and Correlation with Survival in Human Urothelial Carcinoma
Open the PDF for Cancer-Testis Antigens: Expression and Correlation with Survival in Human Urothelial Carcinoma in another window
Includes: Supplementary data
Journal Articles

Pharmacodynamic Analysis of Target Inhibition and Endothelial Cell Death in Tumors Treated with the Vascular Endothelial Growth Factor Receptor Antagonists SU5416 or SU6668

Darren W. Davis, Ryan Takamori, Chandrajit P. Raut, Henry Q. Xiong, Roy S. Herbst, Walter M. Stadler, John V. Heymach, George D. Demetri, Asif Rashid, Yu Shen, Sijin Wen, James L. Abbruzzese, David J. McConkey
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (2): 678–689.
https://doi.org/10.1158/1078-0432.678.11.2
Published: 08 February 2005
View article titled, Pharmacodynamic Analysis of Target Inhibition and Endothelial Cell Death in Tumors Treated with the Vascular Endothelial Growth Factor Receptor Antagonists SU5416 or SU6668
Open the PDF for Pharmacodynamic Analysis of Target Inhibition and Endothelial Cell Death in Tumors Treated with the Vascular Endothelial Growth Factor Receptor Antagonists SU5416 or SU6668 in another window
Journal Articles

Clinical and Biomarker Correlates of Androgen-Independent, Locally Aggressive Prostate Cancer with Limited Metastatic Potential

Vasily J. Assikis, Kim-Anh Do, Sijin Wen, Xuemei Wang, Jeong Hee Cho-Vega, Shawn Brisbay, Remigio Lopez, Christopher J. Logothetis, Patricia Troncoso, Christos N. Papandreou, Timothy J. McDonnell
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (20): 6770–6778.
https://doi.org/10.1158/1078-0432.CCR-04-0275
Published: 22 October 2004
View article titled, Clinical and Biomarker Correlates of Androgen-Independent, Locally Aggressive Prostate Cancer with Limited Metastatic Potential
Open the PDF for Clinical and Biomarker Correlates of Androgen-Independent, Locally Aggressive Prostate Cancer with Limited Metastatic Potential in another window
Journal Articles

Quantitative Analysis of Biomarkers Defines an Optimal Biological Dose for Recombinant Human Endostatin in Primary Human Tumors

Darren W. Davis, Yu Shen, Nizar A. Mullani, Sijin Wen, Roy S. Herbst, Michael O’Reilly, James L. Abbruzzese, David J. McConkey
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (1): 33–42.
https://doi.org/10.1158/1078-0432.CCR-0736-3
Published: 20 January 2004
View article titled, Quantitative Analysis of Biomarkers Defines an Optimal Biological Dose for Recombinant Human Endostatin in Primary Human Tumors
Open the PDF for Quantitative Analysis of Biomarkers Defines an Optimal Biological Dose for Recombinant Human Endostatin in Primary Human Tumors in another window